The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases Clinical article

Journal of Neurosurgery

Volumn 119, Issue 5, 2013, Pages 1131-1138

  Oermann, Eric K ^a,b   Kress, Marie Adele S ^b   Todd, Jonathan V ^c   Collins, Brian T ^b   Hoffman, Riane ^a   Chaudhry, Huma ^b   Collins, Sean P ^b   Morris, David ^a   Ewend, Matthew G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Brain metastases; Local control; Oncology; Radioresistance; Stereotactic radiosurgery

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOBIOLOGY; RADIOSENSITIVITY; RADIOSURGERY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84887098751     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.8.JNS122177     Document Type: Article

References (27)

1. Alexander E III, Moriarty T.M., Davis RB, Wen PY, Fine HA, Black P.M., et al.: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87: 34-40, 1995
2. Aoyama H, Shirato H, Tago M., Nakagawa K, Toyoda T, Hatano K., et al.: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295: 2483-2491, 2006 (Pubitemid 43854963)
3. Bentzen SM, Thames HD, Overgaard J: Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma? Int J Radiat Biol 57: 117-126, 1990 (Pubitemid 20027036)
4. Cannady SB, Cavanaugh KA, Lee S.Y., Bukowski RM, Olencki TE, Stevens GH, et al.: Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Radiat Oncol Biol Phys 58: 253-258, 2004 (Pubitemid 38010360)
5. Chang EL, Selek U, Hassenbusch SJ III, Maor MH, Allen PK, Mahajan A, et al.: Outcome variation among "radioresistant," brain metastases treated with stereotactic radiosurgery. Neurosurgery 56: 936-945, 2005
6. Choi KN, Withers HR, Rotman M: Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation. Cancer 56: 1-9, 1985 (Pubitemid 15022846)
7. Decker DA, Decker VL, Herskovic A, Cummings GD: Brain metastases in patients with renal cell carcinoma: prognosis and treatment. J Clin Oncol 2: 169-173, 1984 (Pubitemid 14138404)
8. DiBiase SJ, Valicenti RK, Schultz D, Xie Y., Gomella LG, Corn BW: Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol 158: 746-749, 1997
9. Ellerhorst J, Strom E, Nardone E., McCutcheon I: Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 49: 93-97, 2001 (Pubitemid 32041280)
10. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, et al.: A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28: 797-802, 1994 (Pubitemid 24099860)
11. Golden DW, Lamborn KR, McDermott M.W., Kunwar S., Wara WM, Nakamura JL, et al.: Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg 109 Suppl: 77-86, 2008
12. Hasegawa T, Kondziolka D, Flickinger J.C., Germanwala A., Lunsford LD: Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 52: 1318-1326, 2003 (Pubitemid 36666947)
13. Kondziolka D, Patel A, Lunsford L.D., Kassam A., Flickinger JC: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45: 427-434, 1999 (Pubitemid 29408559)
14. Lutterbach J, Cyron D, Henne K, Ostertag CB: Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 62 (Suppl 2): 776-784, 2008
15. Oermann E, Collins BT, Erickson K.T., Yu X., Lei S, Suy S, et al.: CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures. J Hematol Oncol 3: 22, 2010
16. Overgaard J: The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 12: 867-872, 1986 (Pubitemid 16057568)
17. Overgaard J, Overgaard M, Hansen P.V., von der Maase H: Some factors of importance in the radiation treatment of malignant melanoma. Radiother Oncol 5: 183-192, 1986 (Pubitemid 16125844)
18. Regine WF, Huhn JL, Patchell R.A., St Clair WH, Strottmann J, Meigooni A, et al.: Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 52: 333-338, 2002 (Pubitemid 34172998)
19. Rofstad EK Fractionation sensitivity (alpha/beta ratio) of human melanoma xenografts. Radiother Oncol 33: 133-138, 1994
20. Rofstad EK: Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma. Cancer Res 52: 4453-4457, 1992
21. Scorsetti M, Facoetti A, Navarria P., Bignardi M, De Santis M, Ninone SA, et al.: Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases. Anticancer Res 29: 4259-4263, 2009
22. Shinoura N, Yamada R, Okamoto K., Nakamura O, Shitara N: Local recurrence of metastatic brain tumor after stereotactic radiosurgery or surgery plus radiation. J Neurooncol 60: 71-77, 2002 (Pubitemid 35153536)
23. Sperduto PW, Kased N, Roberge D., Xu Z, Shanley R, Luo X., et al.: Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30: 419-425, 2012
24. Thames HD J.r., Withers HR, Peters L.J., Fletcher GH: Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 8: 219-226, 1982 (Pubitemid 12139897)
25. Withers HR, Mason KA, Taylor J.M., Kim DK, Smathers JB: Dose-survival curves, alpha/beta ratios, RBE values, and equal ef fect per fraction for neutron irradiation of jejunal crypt cells. Radit Res 134: 295-300, 1993 (Pubitemid 23209251)
26. Wroński M., Arbit E, Burt M., Perino G, Galicich JH, Brennan MF: Resection of brain metastases from sarcoma. Ann Surg Oncol 2: 392-399, 1995
27. Wroński M., Maor MH, Davis B.J., Sawaya R., Levin VA: External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 37: 753-759, 1997 (Pubitemid 27181304)